HotCopper Email Retraction

An email advertisement was sent on or about 11 April 2015 (the Advertisement) detailing the initial public offering of securities (Offer) under the Replacement Prospectus of iQ3Corp Limited ACN 160 238 282 dated 23 February 2015. That email was sent out in error and contained a number of factual inaccuracies and omissions about the details of the Offer. In particular:

1. The Advertisement did not contain a statement that the offer of securities is made in, or accompanied by, a copy of the disclosure document and that you should consider the disclosure document in deciding whether to acquire the securities under the Offer.
2. The sections in the Advertisement titled “The Biotech Industry and the challenges in Australia” and "iQ3Corp's new value proposition for Australian investors" were included in error. iQ3Corp Ltd’s business is primarily focused on providing capital raising and corporate advisory services to listed and unlisted companies in the Life Science industry and not the provision of investment services or products for investors.
3. The Advertisement also mistakenly stated that a priority offer was available to you as a member of the HotCopper network in the event of an oversubscription. The Offer does not include a priority offer for applicants who are members of HotCopper. All applicants will be treated equally under the Offer. In the event that the Offer is oversubscribed, the number of securities allocated to applicants will be at the discretion of the Company.

Please disregard the Advertisement in its entirety. If you have applied under the Offer by using the link provided with the Advertisement, please contact Investor Relations at iQ3Corp Ltd on 02 8239 5400 or at [email protected] as soon as possible so that we can discuss your Application with you. If you applied under the Offer using the link provided and wish to withdraw your application, we propose to repay any money received from you in respect of the Offer.

Disclaimer
The Offer is only made through the Replacement Prospectus which you should consider in deciding whether to apply for securities. To apply, you need to complete the application form in or with the Replacement Prospectus. The Replacement Prospectus may be obtained by requesting a copy at [email protected] or calling 02 8239 5400.
Regards,

Spiro Sakiris. BBus, Dip. Law, ACA
Chief Operating Officer

Levels 3 & 6, 222 Clarence Street, Sydney NSW 2000   
Tel: +61 2 8239 5400